VERA Competitors & Alternatives
Compare Vera Therapeutics Inc with similar stocks in the same industry
Biotechnology
VERA
Main Stock$28.10
Tradestie Score
39
Market Cap
$1.84B
Analyst Upside
+153.9%
Top Competitors
214 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.19
|
$2.23B | - | 47 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.04
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$50.65
|
$2.21B | - | 58 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.74
|
$2.18B | - | 52 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.27
|
$2.08B | - | 35 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.07
|
$2.02B | 802.5 | 41 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$9.70
|
$2.01B | - | 44 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$28.56
|
$1.97B | - | 38 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.21
|
$1.92B | - | 57 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$64.37
|
$1.92B | - | 34 | Compare |
More VERA Analysis
Data updated: Nov 14, 2026 | Industry: Biotechnology (SIC 2834)
214 stocks in this industry